Margaret Brazier
Search for other papers by Margaret Brazier in
Current site
Google Scholar
PubMed
Close
,
Emma Cave
Search for other papers by Emma Cave in
Current site
Google Scholar
PubMed
Close
, and
Rob Heywood
Search for other papers by Rob Heywood in
Current site
Google Scholar
PubMed
Close
Medical products liability
Abstract only
Log-in for full text

During the COVID-19 pandemic, the pharmaceutical industry made unprecedented efforts to collaborate and work in the public interest to develop novel treatments, diagnostics and vaccines. But a long history of opacity, competitiveness and catastrophes mean there is much ground to make up. Starting with the thalidomide tragedy, a series of disasters taught us the painful lesson that drugs can be dangerous and their use must be paid for. This chapter considers routes to redress, focusing on negligence and the Consumer Protection Act.

  • Collapse
  • Expand

All of MUP's digital content including Open Access books and journals is now available on manchesterhive.

 

Metrics

All Time Past Year Past 30 Days
Abstract Views 422 288 10
Full Text Views 66 47 0
PDF Downloads 68 42 0